Cargando…
Registered report: Coadministration of a tumor-penetrating peptide enhances the efficacy of cancer drugs
The Reproducibility Project: Cancer Biology seeks to address growing concerns about reproducibility in scientific research by conducting replications of 50 papers in the field of cancer biology published between 2010 and 2012. This Registered report describes the proposed replication plan of key exp...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4441371/ https://www.ncbi.nlm.nih.gov/pubmed/27879198 http://dx.doi.org/10.7554/eLife.06959 |
_version_ | 1782372780461785088 |
---|---|
author | Kandela, Irawati Chou, James Chow, Kartoa |
author_facet | Kandela, Irawati Chou, James Chow, Kartoa |
author_sort | Kandela, Irawati |
collection | PubMed |
description | The Reproducibility Project: Cancer Biology seeks to address growing concerns about reproducibility in scientific research by conducting replications of 50 papers in the field of cancer biology published between 2010 and 2012. This Registered report describes the proposed replication plan of key experiments from ‘Coadministration of a tumor-penetrating peptide enhances the efficacy of cancer drugs’ by Sugahara and colleagues, published in Science in 2010 (Sugahara et al., 2010). The key experiments being replicated include Figure 2 and Supplemental Figure 9A. In Figure 2, Sugahara and colleagues presented data on the tumor penetrance of doxorubicin (DOX) when co-administered with the peptide iRGD, as well as the effect of co-treatment of DOX and iRGD on tumor weight and cell death. In Supplemental Figure 9A, they tracked body weight of mice treated with DOX and iRGD to provide evidence that iRGD does not increase known DOX toxicity. The Reproducibility Project: Cancer Biology is a collaboration between the Center for Open Science and Science Exchange, and the results of the replications will be published by eLife. DOI: http://dx.doi.org/10.7554/eLife.06959.001 |
format | Online Article Text |
id | pubmed-4441371 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | eLife Sciences Publications, Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-44413712015-05-26 Registered report: Coadministration of a tumor-penetrating peptide enhances the efficacy of cancer drugs Kandela, Irawati Chou, James Chow, Kartoa eLife Human Biology and Medicine The Reproducibility Project: Cancer Biology seeks to address growing concerns about reproducibility in scientific research by conducting replications of 50 papers in the field of cancer biology published between 2010 and 2012. This Registered report describes the proposed replication plan of key experiments from ‘Coadministration of a tumor-penetrating peptide enhances the efficacy of cancer drugs’ by Sugahara and colleagues, published in Science in 2010 (Sugahara et al., 2010). The key experiments being replicated include Figure 2 and Supplemental Figure 9A. In Figure 2, Sugahara and colleagues presented data on the tumor penetrance of doxorubicin (DOX) when co-administered with the peptide iRGD, as well as the effect of co-treatment of DOX and iRGD on tumor weight and cell death. In Supplemental Figure 9A, they tracked body weight of mice treated with DOX and iRGD to provide evidence that iRGD does not increase known DOX toxicity. The Reproducibility Project: Cancer Biology is a collaboration between the Center for Open Science and Science Exchange, and the results of the replications will be published by eLife. DOI: http://dx.doi.org/10.7554/eLife.06959.001 eLife Sciences Publications, Ltd 2015-05-22 /pmc/articles/PMC4441371/ /pubmed/27879198 http://dx.doi.org/10.7554/eLife.06959 Text en © 2015, Kandela et al http://creativecommons.org/licenses/by/4.0/ This article is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use and redistribution provided that the original author and source are credited. |
spellingShingle | Human Biology and Medicine Kandela, Irawati Chou, James Chow, Kartoa Registered report: Coadministration of a tumor-penetrating peptide enhances the efficacy of cancer drugs |
title | Registered report: Coadministration of a tumor-penetrating peptide enhances the efficacy of cancer drugs |
title_full | Registered report: Coadministration of a tumor-penetrating peptide enhances the efficacy of cancer drugs |
title_fullStr | Registered report: Coadministration of a tumor-penetrating peptide enhances the efficacy of cancer drugs |
title_full_unstemmed | Registered report: Coadministration of a tumor-penetrating peptide enhances the efficacy of cancer drugs |
title_short | Registered report: Coadministration of a tumor-penetrating peptide enhances the efficacy of cancer drugs |
title_sort | registered report: coadministration of a tumor-penetrating peptide enhances the efficacy of cancer drugs |
topic | Human Biology and Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4441371/ https://www.ncbi.nlm.nih.gov/pubmed/27879198 http://dx.doi.org/10.7554/eLife.06959 |
work_keys_str_mv | AT kandelairawati registeredreportcoadministrationofatumorpenetratingpeptideenhancestheefficacyofcancerdrugs AT choujames registeredreportcoadministrationofatumorpenetratingpeptideenhancestheefficacyofcancerdrugs AT chowkartoa registeredreportcoadministrationofatumorpenetratingpeptideenhancestheefficacyofcancerdrugs AT registeredreportcoadministrationofatumorpenetratingpeptideenhancestheefficacyofcancerdrugs |